Integrating Lutetium-177-PSMA-617: Sequencing, Combinations, and Safety in Taxane-Naïve mCRPC - Michael Morris
Michael J. Morris
Oliver Sartor speaks with Michael Morris to discuss treatment strategies following the PSMAfore trial, in metastatic castration-resistant prostate cancer after progresson on an androgen receptor pathway inhibitor.